However, as FXR expression is down-regulated in endotoxic mice, FXR synthetic ligands display a poor effect on cholestasis (136), thus advocating for the identification of an alternative therapeutic strategy such as promoting the increase of FXR expression. Here, NR1H4 is linked to cholestasis.